ENOS anticorps (AA 519-690)

N° du produit ABIN7178985

L’anticorps anti-ENOS Polyclonal Lapin est utilisé pour la détection de ENOS dans des échantillons de Rat. Il a été validé pour ELISA.

Aperçu rapide pour ENOS anticorps (AA 519-690) (ABIN7178985)

Antigène: ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Reactivité: Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ENOS est non-conjugé

Application: ELISA

Détail du produit anti-ENOS anticorps

Épitope: AA 519-690

Fonction: Nos3 Antibody

Réactivité croisée: Rat

Purification: Protein G purified

Pureté: >95 %

Immunogène: Recombinant Rat Nitric oxide synthase, endothelial protein (519-690AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur ENOS

Antigène: ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Autre désignation: Nos3

Sujet:

Background: Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.

Aliases: Nos3 antibody, Nitric oxide synthase antibody, endothelial antibody, EC 1.14.13.39 antibody, Constitutive NOS antibody, cNOS antibody, EC-NOS antibody, Endothelial NOS antibody, eNOS antibody, NOS type III antibody, NOSIII antibody

UniProt: Q62600

Pathways: ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling